Clinical Efficacy of Combination Intravenous and Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis

Compared with intravenous chemotherapy alone, the combined intravenous and intraperitoneal chemotherapy was more effective in improving quality of life and extending survival time in patients with abdominal peritoneal carcinomatosis from gastric cancer. In addition, the combination treatment is tolerable and therefore worth further clinical study.